| Date | Title | Description |
| 04.11.2024 | Executing Patient Technology Strategies to Meet Unique Clinical Trial Needs, Upcoming Webinar Hosted by Xtalks | www.iqvia.com/solutions/technologies/orchestrated-clinical-trials
In this free webinar, learn how to design and execute a patient technology strategy that fits a clinical trial's unique needs. Attendees will gain insights into how to reduce... |
| 25.10.2024 | Globality: AI-Based Sourcing And Procurement Company Raises $47 Million | Globality, a market leader in AI-based sourcing and procurement, announced that it raised $47 million in a Series D-1 and Series D-2 preferred stock offering. This offering was supported by the company’s existing preferred shareholders and ... |
| 23.10.2024 | Globality and Ascent Solutions: Two Titans in Tech Funding and Leadership | In the ever-evolving landscape of technology, two companies have recently made headlines for their strategic moves. Globality, a pioneer in AI-driven sourcing and procurement, has secured a hefty $47 million in funding. Meanwhile, Ascent So... |
| 23.10.2024 | The Rise of AI-Driven Solutions: Globality's $47M Funding and Apple's Vision for the Future | In the bustling world of technology, two stories emerge that highlight the transformative power of artificial intelligence (AI) and the relentless pursuit of innovation. Globality, a company based in Palo Alto, California, has recently secu... |
| 22.10.2024 | Globality Raises $47M in Series D-1 and Series D-2 | Globality, a Palo Alto, CA-based company which specializes in AI-driven sourcing and procurement, raised $47M in Series D-1 and Series D-2 funding.
Backers included Rollins Capital, bringing the total capital raised to $356M.
The company in... |
| 11.10.2024 | IQIVIA Launches GenAI Assistant for Life Sciences | What You Should Know:
– IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today introduces IQVIA AI Assistant, a genera... |
| 02.10.2024 | Pfizer's Strategic Shift: Selling Haleon Shares and Precision Medicine's New Leadership | In the ever-evolving landscape of pharmaceuticals, companies often pivot to stay ahead. Pfizer is making waves again. The pharmaceutical giant has announced a significant move: selling its stake in Haleon, the maker of Sensodyne, for a stag... |
| 02.10.2024 | Transforming Clinical Data Management with Clinical Data and Analytics Platforms, Upcoming Webinar Hosted by Xtalks | www.iqvia.com/solutions/technologies/orchestrated-clinical-trials
In this free webinar, gain insights into current business challenges that sponsors face in clinical data management and the impact of these challenges on trial timelines, reg... |
| 01.10.2024 | Precision Medicine Group Welcomes Margaret Keegan as CEO | -- Founding CEO Mark Clein named Executive Chairman; Mr. Clein and co-founder Ethan Leder to continue as Board Directors --
BETHESDA, Md., Oct. 1, 2024 /PRNewswire/ -- Precision Medicine Group (Precision), a leading next-generation provider... |
| 11.09.2024 | IQVIA Applauded by Frost & Sullivan for Improving the Performance of QARA Professionals, Patient Safety, and Commercial Performance with Its AI Solutions | IQVIA's AI solutions streamline workflows, drive automation to connect process improvements, and provide insights into individual activities, improving patient safety and commercial performance.
SAN ANTONIO, Sept. 11, 2024 /PRNewswire/ -- F... |
| 10.09.2024 | Amid Record Growth and Adoption of Judi Clinical Trial Collaboration Platform, AG Mednet Announces New Key Leadership Appointments | BOSTON, Sept. 10, 2024 /PRNewswire/ -- AG Mednet, the pioneering force in clinical trial process management, continues to experience rapid growth and momentum, driven by the widespread adoption of its Judi platform on over 2,000 clinical tr... |
| 16.08.2024 | Moberg Pharma's Strategic Growth Amidst Financial Challenges | Moberg Pharma is navigating a complex landscape in the pharmaceutical industry. Their interim report for January to June 2024 reveals a company in transition. The numbers tell a story of both struggle and success. Net revenue reached SEK 4.... |
| 16.08.2024 | 4G Clinical Announces Appointment of Life Science Service and Tech Leader Dr. Ronan Brown as New Chief Operating Officer | Brown brings years of industry expertise to oversee and maximize 4G Clinical's operational efficiency and excellence.
WELLESLEY, Mass., Aug. 16, 2024 /PRNewswire/ -- 4G Clinical, a global leader in randomization and trial supply management ... |
| 13.08.2024 | Moberg Pharma´s interim report January - June 2024 | Moberg Pharma´s interim report January - June 2024
Tue, Aug 13, 2024 08:00 CET Report this content
TERCLARA IS THE MARKET LEADER IN SWEDEN
SIX-MONTH PERIOD (JAN-JUNE 2024) Net revenue SEK 4.9 million (0) EBITDA SEK -12.7 million (-10.7) Ope... |
| 10.07.2024 | Uncapping Capacity: Solving for Technology Overload in Clinical Trials | Melissa Easy, VP & General Manager of Clinical Technologies, IQVIA
The clinical trial landscape has greatly benefited from technological innovations over the past few decades. Innovation has expanded remote monitoring capabilities, pati... |
| 09.07.2024 | Tecnos Japan Tecnos Japan establishes Tecnos Europe B.V. Through the company, acquires Dutch solution vendor “Trueson B.V.” | [Tecnos Japan] Tecnos Japan establishes Tecnos Europe B.V. Through the company, Tecnos Europe B.V.
Acquired “B.V.”
*Technos Japan*
Press release: July 9, 2024
**
Tecnos Japan establishes Tecnos Europe B.V. Acquires Dutch solution vendor “Tr... |
| 09.07.2024 | Tecnos Japan Tecnos Japan establishes Tecnos Europe B.V. Through the company, acquires Dutch solution vendor “Trueson B.V.” | - |
| 02.07.2024 | New Survey Shows 80 Percent of Adults Experience Skin Concerns, Yet Less than Half Visit a Dermatologist Annually¹ | CeraVe Reveals New Data and Sparks a Movement of Dermatologist Changemakers in Recognition of World Skin Health Day, A Global Initiative Led by the International League of Dermatological Societies (ILDS) and the International Society of Der... |
| 27.06.2024 | Boost All 15 Essential Ceramides with Cetaphil's NEW foam innovation: Cetaphil® Daily Facial Cleanser | The NEW Cetaphil® Daily Facial Cleanser is a gel-to-foam cleanser that boosts all 15 ceramide classes of the skin and offers an effective cleansing experience without compromising the skin's barrier, making it the perfect solution for oily,... |
| 20.06.2024 | JOGO Health Revolutionizes Chronic Pain Treatment with $5.5M Funding Round | JOGO Health, a groundbreaking medtech company based in New York City, has recently closed a significant funding round of $5.5 million. This investment, led by Hourglass Ventures, marks a pivotal moment for JOGO Health as it continues to rev... |
| 18.06.2024 | JOGO Health: $5.5 Million Raised To Treat Neuromuscular Disorders | JOGO Health, a medical technology company treating chronic pain and neuromuscular disorders, announced it has raised over $5.5 million in an investment round led by Hourglass Ventures. And due to high demand, the company is opening the roun... |
| 18.06.2024 | JOGO Health Closes $5.5M in Round Led by Hourglass Ventures, Extends Investment Opportunity for Public to Invest Alongside Mayo Clinic Ventures | By leveraging the brain’s natural neuroplasticity, JOGO Health’s AI-powered patented technology is transforming the treatment of chronic pain and neuromuscular disorders for millions worldwide.
NEW YORK–(BUSINESS WIRE)–June 18, 2024–
JOGO H... |
| 18.06.2024 | CeQur Simplicity™, a Wearable Mealtime Insulin Delivery Device, Obtains FDA-Clearance for 4 Days of Wear to Further Simplify Diabetes Management | CeQur Simplicity 4-Day Wearable Insulin Patch
The CeQur Simplicity patch is now FDA-cleared for up to 4 days of wear. Each patch replaces up to 12 injections further simplifying mealtime insulin management.
HORW, Switzerland, June 18, 2024 ... |
| 17.06.2024 | Alembic Pharma gets USFDA Final Approval for Icatibant Injection | Alembic Pharmaceuticals Limited announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Icatibant Injection used for treatment of acute attacks of ... |
| 14.06.2024 | Upcoming Presentations by Staff and Affiliates of CBO's Health Analysis Division | This summer, several of my colleagues in the Congressional Budget Office’s Health Analysis Division will share their work with the public, giving a total of five presentations—one at the 2024 IQVIA Institute Research Forum in Boston, Massac... |
| 12.06.2024 | ETQ, Dassault Systèmes, Siemens, PTC, ComplianceQuest, Intellect, and Rockwell Automation are Leaders in ABI Research's QMS Software Competitive Ranking | NEW YORK, June 12, 2024 /PRNewswire/ -- The new Competitive Assessment by global technology intelligence firm ABI Research provides an in-depth and unbiased examination of the solutions offered by nineteen Quality Management System (QMS) so... |
| 05.06.2024 | Raleigh's First Citizens lands spot on Fortune 500 list | figcaption>span]:font-sans">
First Citizens Bank, founded 125 years ago in Johnston County, is the Triangle's newest Fortune 500 company, entering the annual list of the country's largest companies by revenue at No. 182.
State of... |
| 29.05.2024 | QMS Software Market to Reach US$13.7 Billion by 2034, Driven by AI Innovations and Quality Focus | SINGAPORE, May 29, 2024 /PRNewswire/ -- The escalating demand for product quality from customers, spurred by news cycles highlighting issues across industries such as aerospace, pharmaceuticals, and automotive, is driving significant growth... |
| 24.05.2024 | Lilly invests further $5.3 bln in new Indiana site as obesity drug demand soars | Healthcare & PharmaceuticalsLilly invests further $5.3 bln in new Indiana site as obesity drug demand soars
By Patrick WingroveMay 24, 20243:32 PM UTCUpdated ago
Save
Text
Small Text
Medium Text
Large Text
Share
Twitter
Facebook
Linkedi... |
| 22.05.2024 | Cipla receives final approval for the generic version of Somatuline® Depot (Lanreotide) Injection 120 mg/ 0.5 mL, 90 mg/0.3 mL, 60 mg/0.2 mL | MUMBAI, India and WARREN, N.J., May 22, 2024 /PRNewswire/ -- Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla") and its wholly owned subsidiary Cipla USA Inc., (hereafter referred to as "Cipla&qu... |
| 20.05.2024 | Terclara is the market leader in Sweden | Terclara is the market leader in Sweden
Mon, May 20, 2024 08:00 CET Report this content
Moberg Pharma AB (OMX: MOB) announces that Terclara® is the market leader in Sweden for the month of April, the first full month the product is availabl... |
| 15.05.2024 | Vanda Pharmaceuticals Reports Positive Results from a Second Phase III Study of Tradipitant in Motion Sickness | • New Drug Application expected to be submitted in Q4 2024
WASHINGTON, May 15, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the results from its second Phase III study of tradipitant in motion sickn... |
| 10.05.2024 | Kexing Biopharm Facility Passes EU GMP Certification for Paclitaxel for Injection (Albumin Bound) | SHENZHEN, China, May 10, 2024 /PRNewswire/ -- On the evening of May 5, Kexing Biopharm (stock code: 688136) announced it had obtained a "Certificate of GMP Compliance of a Manufacturer" granted by the Norwegian Medical Products Ag... |
| 29.04.2024 | North Carolina's rich list includes Jim Goodnight and Tim Sweeney again | figcaption>span]:font-sans">
James Goodnight, co-founder and CEO of the Cary data analytics firm SAS, remains North Carolina's wealthiest resident, according to Forbes' recently released list of the world's billionaires.
The big ... |
| 23.04.2024 | AI-powered data management: Navigating data complexity in clinical trials | The data flood gates have opened wide for clinical trial research. In fact, the amount of data gathered may be more akin to a tsunami or a monsoon. For decades, researchers struggled with a lack of data available in clinical trials; however... |
| 18.04.2024 | Strategies for Biomarker-Driven Sub-population Optimization in Clinical Trials, Upcoming Webinar Hosted by Xtalks | www.iqvia.com/solutions/technologies/orchestrated-clinical-trials
In this free webinar, review and understand the transformative impact of a biomarker-driven approach to identify sub-populations in clinical trials. Attendees will discover h... |
| 11.04.2024 | Nuevocor Strengthens Leadership Team with Appointment of John Lee as Chief Medical Officer | SINGAPORE and PHILADELPHIA, April 11, 2024 /PRNewswire/ -- Nuevocor, a pre-clinical stage biotechnology company dedicated to developing novel medicines to treat cardiomyopathies with aberrant mechanobiology, today announces the appointment ... |
| 14.03.2024 | Global Medical Device Outsourcing Market Forecast 2024-2033 – Market Size, Drivers, Trends, And Competitors | Medical Device Outsourcing Global Market Report 2024 : Market Size, Trends, And Global Forecast 2024-2033
The Business Research Company's Medical Device Outsourcing Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2... |
| 12.03.2024 | Real World Evidence/RWE Solutions Market is growing at a CAGR of 13.8% from 2024 to 2030 by Exactitude Consultancy | Real World Evidence (RWE) Solutions market
The Exactitude Consultancy Real World Evidence/RWE Solutions Market Report – Size, Trends, and Forecast 2024-2030
The Real World Evidence (RWE) Solutions market is experiencing high demand due to i... |
| 11.03.2024 | Patient Recruitment and Retention Services Global Market Report 2024 | - |
| 07.03.2024 | Oncology-Based In-Vivo CRO Market Projected for Vigorous Growth, North America Leads Regional Shares | - |
| 06.03.2024 | Life Sciences Next Gen Customer Engagement Platform Market | Veeva, Pitcher, Exeevo, IQVIA, Salesforce, Trueblue, WhizAI, ACTO, Viseven, Aktana, Seismic, Allego, ODAIA, Bigtincan, and Tellius, among others are some of the key players operating in the global market.
According to a new market research ... |
| 01.12.2023 | Biocon Biologics Successfully Completes Integration of Viatris' Biosimilar Business in 31 Countries in Europe | BENGALURU, India, Dec. 1, 2023 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the integration of the Viatris' biosimilars business in 31 European countries has be... |
| 21.11.2023 | Filling 12-month prescriptions is one practical way to help the pharmacist crisis | Pharmacies could be called the most “rock solid” entity in our health care system. Even before Covid, pharmacies were held in high esteem; during the pandemic, they raised their game by making it easy for tens of millions of Americans to ge... |
| 26.09.2023 | The problem with potential changes to the biosimilar regulatory framework | Biosimilars are no longer a new and untested class of medicines. Today, they provide critical treatment options across multiple therapeutic areas. Since the Biologics Price Competition and Innovation Act of 2009 created a regulatory pathway... |
| 01.09.2023 | The Self-Driving Clinical Trial: Optimizing Research with AI and ML | The power and potential of artificial intelligence (AI) and machine learning (ML) in the healthcare industry are unparalleled. The use of automated technology systems like digital workflows, orchestration and storing of data digitally is he... |
| 28.08.2023 | What do new weight loss drugs mean for the future of bariatric surgery? | Over the past year, weight loss drugs have captured the public’s imagination but also raised existential questions about the future of bariatric surgery.
For obesity, surgery has long been — and continues to be — the most effective treatmen... |
| 12.07.2023 | IQVIA’s SmartSolve® eQMS Named “Best New Technology Solution for Drug Development” in 2023 MedTech Breakthrough Awards Program | IQVIA Wins 2023 MedTech Breakthrough Award “SmartSolve enables organizations to drive continuous improvement in quality across global operations, and increase focus on ‘go-to-market, grow-in-market, stay-in-market’ organizational priorities... |
| 27.06.2023 | IQVIA Launches RIM Smart Labeling to Deliver Intelligence-Driven Approach for Global Label Management | IQVIA announced the launch of IQVIA RIM Smart Labeling, a comprehensive labeling solution for the life sciences industry that provides an intelligence-driven approach for more efficient and compliant global label management. Through this un... |
| 09.05.2023 | The IRA’s nonsensical distinction between small- and large-molecule drugs | Thanks to advances in science, notably the completion of the Human Genome Project 20 years ago, we are able to treat diseases more effectively than ever before. Researchers have more sophisticated tools not only to identify new drug targets... |
| 14.04.2023 | I’m a biopharma supply chain specialist — and even I can’t find the Adderall I’m prescribed | For 10 years, I have depended on Adderall to help me function. But in February, for the first time, the pharmacy down the street was unable to fill my prescription. In fact, 19 pharmacies in a row told me that they were out of stock. Thankf... |
| 27.02.2023 | IFPW Launches Environmental, Social, and Corporate Governance (ESG) Framework as a Pharmaceutical Industry Resource | The global pharmaceutical wholesalers' association has developed a collaborative framework to help organizations navigate ESG topics and share best practices.
MANASSAS, VIRGINIA, UNITED STATES, February 27, 2023 /EINPresswire.com/ -- The In... |
| 20.02.2023 | 5 Components of a Patient-Centric eCOA Strategy for Oncology Clinical Trials | Melissa Mooney, Director of eCOA Solutions Engineering at IQVIA
In the US alone, an estimated 1.9 million new cases of cancer were diagnosed in 2022, positioning oncology as a key subject of clinical research. Throughout oncology trial deve... |
| 31.01.2023 | IQVIA in Collaboration with Alibaba Cloud to Deliver Commercial & Clinical Solutions | Leading technology providers come together to bring innovative solutions addressing the unique business and compliance needs of the Greater China Region
IQVIA, a leading global provider of advanced analytics, technology solutions and clinic... |
| 09.12.2022 | FDA Accepts Biogen Biologics License Application for BIIB800, A Biosimilar Candidate Referencing ACTEMRA® (tocilizumab) | /EIN News/ -- CAMBRIDGE, Mass., Dec. 09, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – announced that the U.S. Food and Drug Administration (FDA) has accepted for review the abbreviated Biologics License Application (aBLA) for BIIB8... |
| 23.09.2022 | Market share isn’t the only metric for biosimilars’ success | Market share is often held up as the most relevant metric for the success of a biosimilar class. I believe there are other metrics, like cost savings or signs of greater patient access, that should also be used to define biosimilars’ succes... |
| 23.09.2022 | Lyfegen raises $8M for its value-based drug contracting platform | Specialty medication prices in the U.S. are out of control. Despite making up about 2% of overall prescription volume, specialty drugs accounted for 53% of total annual pharmacy spending last year — up from 27% in 2010 — caused in part by g... |
| 21.09.2022 | Lyfegen secures $8 million to drive down drug costs | |
| 21.09.2022 | Humanizing the digital experience in healthcare | Ask any person to describe their experience with digital healthcare technology and they are likely to use adjectives such as complicated, frustrating and impersonal. The current tangle of electronic health systems, siloed point solutions an... |
| 20.09.2022 | Lyfegen Raises $8M for Value-Based Contracting for High-Cost Drugs | What You Should Know:
Currently, less than 2% of the health insurance population requiring specialty drugs is responsible for 51% of drug spending. The cost of specialty drugs in the US is spiraling out of control, increasing 12% from 2020 ... |
| 15.08.2022 | Connected Devices Selection: Considerations for A Digital-First Approach to Data Collection
| Mark Mentzer, Senior Director, Business Development, Connected Devices and eCOA, IQVIA
In recent years, digital health technologies (DHTs) have significantly changed the way we collect data within clinical trials. This is partially due to t... |
| 09.08.2022 | Here’s who Democrats’ drug pricing bill will actually help | WASHINGTON — Millions of patients in the Medicare program could eventually see lower prescription drug costs if Democrats pass their latest drug pricing plan into law.
The plan, which cleared a major hurdle Sunday when the Senate very narro... |
| 04.08.2022 | The outsized effect of ‘modest’ price controls on pharmaceutical innovation | Drug price controls in the U.S. Senate are being met with dire warnings that such an approach will stifle innovation, shut off the pipeline of new medicines, and cost lives down the road. Is innovation so fragile that a modest reduction in ... |
| 30.06.2022 | PBMs are inflating the cost of generic drugs. They must be reined in | These are not comfortable days in Washington for pharmacy benefit managers, the highly consolidated group of intermediaries that sit astride the drug supply chain. The Federal Trade Commission and Capitol Hill want to know how the PBMs’ arc... |
| 29.06.2022 | Reimagining The Future of Pharmacovigilance (PV): Regulations, Tech, Public Perceptions | Barry Mulchrone, Senior Director& Head of Pharmacovigilance Oversight and Analytics, IQVIAAnnette Williams, VP & Global Head, Lifecycle Safety, IQVIA
Monitoring the safe and effective use of medicines has now been an essential part ... |
| 19.05.2022 | ePROs: Better Patient Input for Better Trial Output | Kris Gustafson, Vice President and Global Head Patient Centered Technologies, IQVIA
During the pandemic, electronic clinical outcomes assessments (eCOAs) gained prominence as sponsors looked for more agile tools to help them capture patient... |
| 13.05.2022 | Avanos Medical Recalls Cortrak*2 Enteral Access System for Risk of Misplaced Enteral Tubes Could Cause Patient Harm | The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Product
Product Name: Avanos Medical Cortrak*2 Enteral Access System
Product Codes and Seri... |
| 11.05.2022 | How Web3 and Cloud3 will power collaborative problem-solving and a stronger workforce | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
The onset of the COVID-19 pandemic propelled clou... |
| 05.05.2022 | TIKOMED and IQVIA announce a strategic collaboration for the development of TIKOMED’s lead drug platform candidate ILB® | TIKOMED and IQVIA announce a strategic collaboration for the development of TIKOMED’s lead drug platform candidate ILB®
Thu, May 05, 2022 10:00 CET Report this content
Viken – 5th May, 2022 – Today, Swedish biopharmaceutical company TikoMed... |
| 26.04.2022 | Virgin Pulse Adds New Partners and Expanded Offerings to VP+ Program, Providing More Options for Addressing Health and Wellbeing Needs via Homebase for Health® | PROVIDENCE, R.I., April 26, 2022 (GLOBE NEWSWIRE) -- Virgin Pulse, the leading global digital-first health and wellbeing company, today announced the addition of five new or expanded partners to its VP+ partner program to provide more acces... |
| 13.04.2022 | Incentives to spur repurposing of existing generics for novel uses would open a new paradigm in drug R&D | The Drug Price Competition and Patent Term Restoration Act of 1984, better known as the Hatch-Waxman Act, which enabled the regulatory process for generic drugs, has been remarkably successful. Generic drugs now represent about 90% of presc... |
| 12.04.2022 | Thousands of layoffs planned as part of Novartis restructuring — report | Novartis’ sweeping restructuring will reportedly lead to thousands of job cuts worldwide, including a “three-digit number” in its home of Switzerland.
UPDATED: Novartis CEO Vas Narasimhan restructures the pharma gian... |
| 12.04.2022 | Thousands of layoffs planned as part of Novartis restructuring — report | Gilead can breathe a sigh of relief as the FDA lifts a partial hold on the “breakthrough” CD47 drug magrolimab — although the company is not quite off the hook yet.
After reviewing “comprehensive safety data,” regulators have removed the pa... |
| 12.04.2022 | Thousands of layoffs planned as part of Novartis restructuring — report | Johnson & Johnson’s Janssen is pointing in a positive, new direction for its Crohn’s disease and ulcerative colitis brand Stelara.
The new campaign called “UnstoppaBOLD” is purposeful in encouraging patients to get back to their “authen... |
| 11.04.2022 | Ballooning 340B market reaches almost 15% of 2021 US pharma sales, IQVIA finds | The tale of a booming federal drug discount program, which pharma companies have sought to curtail, has often been told but rarely with new numbers.
Now, the drug pricing gurus at IQVIA say their latest data shows that the pr... |
| 11.04.2022 | Hours after Pfizer, Moderna names its own new CFO with dental, healthcare and auto chops | Roughly two hours after Pfizer named its new CFO, its Covid-19 vaccine competitor Moderna chalked up its own new CFO with a résumé steeped in healthcare, dental equipment and auto manufacturing.
Moderna’s current CFO, Da... |
| 11.04.2022 | Covid-19 roundup: Gavi raises $4.8B in pledged funds; Japan cancels order of 40M remaining AstraZeneca shots | Now roughly two years into the Covax initiative, the global vaccine alliance group Gavi has been trying to raise new money — and now has received pledges of $4.8 billion in funding.
The promised investment was announced on ... |
| 11.04.2022 | Merck extends pact with NK cell specialists at Artiva; Regeneron-allied biotech pencils in $15M IPO | More than a year into its discovery pact with the NK cell specialists at Artiva, Merck is apparently happy with what it’s seen so far.
So happy, in fact, that it wants to try new things with the platform.
The pharma giant has... |
| 11.04.2022 | BioNTech to explore potential of delivering mRNA vaccines orally with new partner | After a Covid-19 vaccine success with partner Pfizer, and as the rest of its mRNA pipeline starts churning out data, BioNTech wants to go another delivery route with its jabs: orally.
The German biotech is paying an undiscl... |
| 11.04.2022 | Pharma firms make new pledge to launch in all Euro markets at least 2 years post-authorization | As part of a drive to increase new meds across Europe, member companies of the continent’s largest pharma lobbying organization have set a new goal to seek pricing and reimbursement in all EU countries no later than 2 y... |
| 11.04.2022 | Vanda takes FDA to court again, this time seeking more info on a rejection letter | After a previous court loss to FDA in early 2020 over a clinical hold, Vanda Pharmaceuticals returned to sue the agency again last week in the same DC district court, alleging this time that the agency is wrongfully withho... |
| 23.03.2022 | Как мобильные приложения помогают бороться с хроническими заболеваниями | Согласно отчету IQVIA Institute, в 2017 году существовало 318,5 тысяч медицинских мобильных приложений, и их количество увеличивалось на 200 ежедневно. 40% из них предназначены для пользователей с самыми разными заболеваниями — от диабета и... |
| 18.03.2022 | If pharma can market to youths by TikTok, it should include them in clinical trials | The pharmaceutical industry has rapidly adapted to promoting prescription drugs to young people on TikTok, Instagram, and other social media platforms, yet it can’t be troubled to include adolescents and young adults in clinical trials for ... |
| 10.02.2022 | Slovenian healthtech app Mediately raises €7.2M to make medical knowledge accessible across Europe | Ljubljana, Slovenia ~
Company:
Mediately, the Slovenian mobile and web app that makes drug information accessible to doctors, has just raised €7.2M in Series A to expand across more European markets. The round is led by the London-based Pit... |
| 07.01.2022 | 2022 predictions: Simpler, trusted health intelligence sharing | We all know some of the complexity in healthcare is unavoidable. It takes a wide range of organizations to ensure patients are cared for, and it’s no small task to understand their needs and balance their interests. But the last two years h... |
| 31.12.2021 | How Northwestern’s Catalyst Lab scales healthy behavior program with Couchbase | Hear from CIOs, CTOs, and other C-level and senior execs on data and AI strategies at the Future of Work Summit this January 12, 2022. Learn more
There’s no shortage of digital health apps on the market — more than 350,000, in fact, accordi... |
| 31.12.2021 | How Northwestern’s Catalyst Lab scales healthy behavior program with Couchbase | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
There’s no shortage of digital health apps on the... |
| 27.12.2021 | Хорошо жить долго: ученые и биохакеры в поисках «таблетки молодости» | Биохакер Дэйв Эспри, тот самый, который изобрел «пуленепробиваемый кофе» с маслом, мечтает дожить до 180 лет. Пионер в области облачных вычислений, как и многие другие обитатели Кремниевой долины, занимается проблемой долголетия всерьез. Би... |
| 15.12.2021 | SOFTWARE AS A MEDICAL DEVICE (SaMD). Часть 2: платформы, меняющие облик индустрии цифрового здравоохранения | SOFTWARE AS A MEDICAL DEVICE (SaMD). Часть 2: платформы, меняющие облик индустрии цифрового здравоохранения |
| 02.12.2021 | IQVIA Recognized As A Leader In BPO Solutions For Pharmaceutical Sales And Marketing | IQVIA recognized in IDC MarketScape for its data and analytics capabilities and growing suite of software platforms
IQVIA a leading global provider of advanced analytics, technology solutions, and clinical research services to the life scie... |
| 02.12.2021 | Omnicell : to Acquire ReCept - Form 8-K | Omnicell to Acquire ReCept
Strategic acquisition of leading specialty pharmacy management services provider supports the Autonomous Pharmacy vision and expands Omnicell's Advanced Services portfolio
Addresses significant need for access to ... |
| 06.11.2021 | The hurried push by Congress to address drug costs shouldn’t undermine the vast savings from generics and biosimilars | Americans rightfully expect Congress to address the ever-increasing prices of brand-name prescription drugs. But the wholesale policy changes now under rushed consideration in Congress will undermine the only proven solution to this long-st... |
| 04.11.2021 | Virgin Pulse Adds 7 Partners to Homebase for Health®, Expanding Global Options for Addressing Top Corporate Health and Wellbeing Concerns | Integrated Partner Ecosystem and Solutions Unlock Value of Health and Wellbeing Investments
PROVIDENCE, R.I., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Virgin Pulse, the leading global provider of tech-enabled solutions focused on improving the hea... |
| 04.11.2021 | Virgin Pulse Adds 7 Partners to Homebase for Health®, Expanding Global Options for Addressing Top Corporate Health and Wellbeing Concerns | Integrated Partner Ecosystem and Solutions Unlock Value of Health and Wellbeing Investments
PROVIDENCE, R.I., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Virgin Pulse, the leading global provider of tech-enabled solutions focused on improving the hea... |
| 04.11.2021 | Is the U.S. at a tipping point with biosimilars? | Is the U.S. at a tipping point with biosimilars?
11/04/2021
By Heidi Hunter, President, Cardinal Health Specialty Solutions at Cardinal Health
This week marks Global Biosimilars Week - a time when healthcare stakeholders around the world ar... |
| 21.10.2021 | IQVIA : Reports Third-Quarter 2021 Results and Raises Full-Year 2021 Guidance - Form 8-K | IQVIA Reports Third-Quarter 2021 Results and Raises Full-Year 2021 Guidance
Revenue of $3,391 million for the third quarter grew 21.7 percent year-over-year
GAAP Net Income of $261 million for the third quarter grew 158.4 percent year-over-... |
| 08.10.2021 | Biosimilars competition helps patients more than generic competition | Much of the current drug-pricing agenda proposed by President Biden and by Congress is based on the belief that greater government control — rather than free market competition — is the best way to lower drug prices. This view that competit... |
| 24.09.2021 | This Entrepreneur Proved That Startups Can Reinvent Themselves When Necessary | Chris Riley, Co-founder of USA RxChris Riley |
| 20.09.2021 | Health apps have to publicize data breaches, but that won’t stymie consumer uptake | The news: The FTC agreed on a policy requiring app makers capturing sensitive consumer data and health records to inform the FTC, US consumers, and in some cases, the media in the event of any security breaches.
Failure to comply could resu... |
| 01.09.2021 | IQVIA Launches New AI-Powered MI Contact Center For Life Sciences | IQVIA, a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, announced it has added new AI-powered technologies to enhance its existing Medical Information (MI) Contact ... |
